Saudi investors exit Pakistan’s largest pharmacy chain. What happened and why?
From its origins as part of the Servis Group to multiple changes in ownership since its inception in 2005, Servaid has undergone an eventful two decades in existence
The magic pill for the pharma sector
Will the deregulation in drug pricing policy prove to be the long awaited cure for the pharmaceutical industry?
AGP acquires portfolio of products from American pharma firm Viatris
AGP claims newly acquired products will add Rs20b to annual revenues
PPMA vs DRAP: Pharma crisis continuesÂ
Unavailability of medicines could inevitably trigger national health emergency
Pricing dispute causes shortage of critical medicine
Pharma companies stop, limit production of scores of essential and non-essential medicines as govt rejects demand for 38% hike in prices
Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen
WASHNGTON: Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatments portfolio, as...
The mechanics behind the panadol shortage
Raids, hoarding and over regulating — You probably need a Panadol to figure out what’s going on
Where did all the Burnol go?
The household product is missing from pharmacies in Pakistan. But its brand recall still holds
Pharmaceuticals: how the locals are beating the multinationals
In a heavily regulated market, the local players have learned to live with the price rules the way they are, while the foreign players still seem to have hope that things will change
UK report claims Pakistan’s Covid-19 medicine enough for national demand
Pakistan, along with India, is the only one among developing countries to have effectively stored enough of Remdesivir to meet their national...
Pharma industry protests govt’s refusal to increase drug prices
LAHORE: The Ministry of National Health Service Regulations and Coordination on Monday announced that there will be no immediate increase in drug...
Pharmaceuticals in Pakistan: extracting whatever they can from the pie
Can the pharmaceutical sector ever be reformed? Kabeer Dawani and Asad Sayeed take a look at the sector’s pitfalls, and ways forward.
Govt takes away drug pricing power from pharmaceutical companiesÂ
ISLAMABAD: The federal government has put an end to the power of pharmaceutical companies to increase prices of drugs while not paying...
Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine
LONDON: Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline (GSK) for 60 million...
Ferozsons dissociates itself from marketing of unlicensed Covid-19 treatment imported from Bangladesh
Ferozsons Laboratories Limited has dissociated itself from the launch of an unlicensed treatment for Covid-19, being imported from Bangladesh.
Clarifying its position, the...